LINA REJOUB: Open Payments
NPI 1346956950 · FLORISSANT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$473 in 20 payments from 9 companies in 2025. Trend: 2023 $325 · 2024 $618 · 2025 $473
Food & beverage: $473
| Company | Payments | Amount |
|---|---|---|
| AtriCure, Inc. | 8 | $207 |
| Novo Nordisk Inc | 3 | $91 |
| Philips North America LLC | 3 | $77 |
| Actelion Pharmaceuticals US, Inc. | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| AltaThera Pharmaceuticals LLC | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
| CVRx, Inc. | 1 | $8 |
Products named: EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, Wegovy, Event, OPSYNVI, Extended Holter, CAMZYOS, Sotalol Hydrochloride, LOKELMA.
Industry payments across MO — which companies pay providers there.
